Drug Interactions between Fosrenol and Sensipar
This report displays the potential drug interactions for the following 2 drugs:
- Fosrenol (lanthanum carbonate)
- Sensipar (cinacalcet)
Interactions between your drugs
No interactions were found between Fosrenol and Sensipar. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Fosrenol is in the drug class phosphate binders.
- Fosrenol is used to treat Hyperphosphatemia of Renal Failure.
- Sensipar is in the drug class calcimimetics.
- Sensipar is used to treat the following conditions:
Drug and food interactions
Applies to: Sensipar (cinacalcet)
Food can enhance the levels of cinacalcet in your body. Cinacalcet should be taken just after eating food. Do not take it on an empty stomach. This will make it easier for your body to absorb the medication. Do not crush, chew, or break the tablets. Swallow them whole.
lanthanum carbonate food
Applies to: Fosrenol (lanthanum carbonate)
Take lanthanum carbonate tablets with food or immediately after a meal to increase absorption by the body. Lanthanum carbonate tablets cannot be dissolved in water and therefore should not be given through feeding tubes because the tube may become clogged. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.